| The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review R Boissier, J Campagna, N Branger, G Karsenty, E Lechevallier Urologic Oncology: Seminars and Original Investigations 35 (4), 135-141, 2017 | 84 | 2017 |
| Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer S Karaki, S Benizri, R Mejías, V Baylot, N Branger, T Nguyen, B Vialet, ... Journal of Controlled Release 258, 1-9, 2017 | 60 | 2017 |
| Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real‐life experience N Branger, T Maubon, M Traumann, J Thomassin‐Piana, N Brandone, ... Bju international 119 (3), 449-455, 2017 | 48 | 2017 |
| Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up Y Koskas, F Lannes, N Branger, S Giusiano, N Guibert, G Pignot, J Walz, ... BMC urology 19, 1-8, 2019 | 33 | 2019 |
| Impact of the extent of extraprostatic extension defined by Epstein’s method in patients with negative surgical margins and negative lymph node invasion T Maubon, N Branger, C Bastide, G Lonjon, KA Harvey-Bryan, P Validire, ... Prostate Cancer and Prostatic Diseases 19 (3), 317-321, 2016 | 25 | 2016 |
| LEM-domain proteins are lost during human spermiogenesis but BAF and BAF-L persist RA Elkhatib, M Paci, R Boissier, G Longepied, Y Auguste, V Achard, ... Reproduction 154 (4), 387-401, 2017 | 18 | 2017 |
| “Real-world” evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy V Niziers, R Boissier, D Borchiellini, JL Deville, C Khoury, M Durand, ... Urologic Oncology: Seminars and Original Investigations 38 (1), 2. e1-2. e9, 2020 | 14 | 2020 |
| Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy. P Regnier, S Brunelle, P Sfumato, J Walz, S Rybikowski, T Maubon, ... Minerva Urology and Nephrology 73 (2), 215-224, 2020 | 12 | 2020 |
| Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG unresponsive non-muscle invasive bladder cancer patients T Marquette, J Walz, S Rybikowski, T Maubon, N Branger, S Fakhfakh, ... Progres en Urologie: Journal de L'association Francaise D'urologie et de la …, 2019 | 10 | 2019 |
| External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer … V Lorusso, B Kabre, G Pignot, N Branger, A Pacchetti, J Thomassin-Piana, ... World Journal of Urology 41 (3), 619-625, 2023 | 9 | 2023 |
| Comparison between Micro-ultrasound and Multiparametric MRI regarding the correct identification of prostate Cancer lesions V Lorusso, B Kabre, G Pignot, N Branger, A Pacchetti, J Thomassin-Piana, ... Clinical Genitourinary Cancer 20 (4), e339-e345, 2022 | 9 | 2022 |
| Sexual-sparing robot assisted radical cystectomy in female: a step-by-step guide A Pacchetti, G Pignot, A Le Quellec, S Rybikowski, T Maubon, N Branger, ... Urology 156, 322-323, 2021 | 9 | 2021 |
| Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and … R Lehrer, F Cornelis, JC Bernhard, P Bigot, C Champy, F Bruyère, ... European Radiology 33 (12), 8426-8435, 2023 | 5 | 2023 |
| Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study N Branger, P Bigot, G Pignot, V Lorusso, F Audenet, B Parier, N Doumerc, ... World Journal of Urology 41 (2), 483-489, 2023 | 5 | 2023 |
| Positive surgical margin’s impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96) A Morrone, I Bentellis, JC Bernhard, K Bensalah, C Champy, F Bruyere, ... Scientific Reports 12 (1), 18342, 2022 | 5 | 2022 |
| Impact of active surveillance for prostate cancer on the risk of depression and anxiety D Sypre, G Pignot, R Touzani, P Marino, J Walz, S Rybikowski, T Maubon, ... Scientific Reports 12 (1), 12889, 2022 | 5 | 2022 |
| French AFU Cancer Committee Guidelines-Update 2022-2024: testicular germ cell cancer T Murez, A Fléchon, N Branger, PH Savoie, L Rocher, P Camparo, ... Progrès en Urologie 32 (15), 1066-1101, 2022 | 4 | 2022 |
| French AFU Cancer Committee Guidelines-Update 2022-2024: penile cancer PH Savoie, T Murez, P Neuville, L Ferretti, L Rocher, A Van Hove, ... Progrès en Urologie 32 (15), 1010-1039, 2022 | 3 | 2022 |
| Impact of renal cell carcinoma histological variants on recurrence after partial nephrectomy: a multi-institutional, prospective study (UROCCR study 82) T Tabourin, U Pinar, J Parra, C Vaessen, CK Bensalah, F Audenet, ... Annals of Surgical Oncology 29 (11), 7218-7228, 2022 | 3 | 2022 |
| Prehabilitation in urology: trial update C Rion, N Branger, T Maubon, S Rybikowski, G Pignot, J Walz European Urology Focus 10 (1), 8-10, 2024 | 2 | 2024 |
